Heparin Induced Thrombocytopenia 4Ts Score

Low score may aid in ruling out HIT(high-negative predictive value)

A clinical pretest probability tool that scores thrombocytopenia, timing, thrombosis, and alternative causes to estimate the likelihood of HIT.

Platelet Count for Thrombocytopenia?
Fall less than 30%, platelet nadir less than 100Fall 30-50%, platelet nadir 10-19+1Fall greater than 50%, platelet nadir 20 or greater+2
Timing of Platelet Count Fall?
Fall less than 4 days without recent exposure05-10 days fall/not clear/onset greater than 10 days/fall less than 1 day/prior heparin exposure 30-100 days+1Fall less than 4 days without recent exposure+2
Are there Thrombosis or other sequelae?
None0Progressive/recurrent; non-necrotizing erythematous skin lesions; not proven+1New confirmed; skin necrosis; acute systemic reaction post-IV UFH bolus+2
Other possible causes of thrombocytopenia?
Definite other etiology0Possible other etiology+1No other apparent etiology+2

Indications for Use

Used when HIT is clinically suspected in any patient recently exposed to heparin. A low score reliably excludes HIT (NPV 0.998) per meta‑analysis of 3068 patients 1 [Level I evidence]. Intermediate/high scores indicate need for immediate heparin cessation, non‑heparin anticoagulation, and HIT immunoassay testing per ASH guideline recommendation 2 [Level I evidence].

Insights & Cautions

Rules out HIT reliably when low probability, but intermediate/high scores are nonspecific and require confirmatory testing. A low score has a 99.8% NPV 1 [Level I evidence], yet specificity is poor (~47%) even at ≥4 2 [Level II evidence]. Overestimation leads to unnecessary non‑heparin anticoagulation and bleeding. ASH strongly recommends using it over gestalt but avoiding testing/treatment when low probability 3 [Level I evidence].